Erik Akhund
Corporate Officer/Principal bei Quadrant Capital Advisors, Inc.
Profil
Erik Akhund is currently a Managing Director at Quadrant Capital Advisors, Inc. He was previously a Director at Melinta Subsidiary Corp.
He obtained an undergraduate degree from The Trustees of Columbia University in The City of New York and an MBA from INSEAD.
Aktive Positionen von Erik Akhund
| Unternehmen | Position | Beginn |
|---|---|---|
Quadrant Capital Advisors, Inc.
 Quadrant Capital Advisors, Inc. Investment ManagersFinance Quadrant Capital Advisors, Inc. provides investment advisory services. The company was founded on March 04, 2003 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Erik Akhund
| Unternehmen | Position | Ende |
|---|---|---|
Melinta Subsidiary Corp.
 Melinta Subsidiary Corp. Pharmaceuticals: MajorHealth Technology Melinta Subsidiary Corp. develops and markets pharmaceutical products for the treatment of life-threatening infections. It also develops novel classes of antibiotics to treat the multi- and extremely-drug-resistant pathogens for which there are few to no options, known collectively as ESKAPE pathogens. The company was founded by John N. Abelson, Harry F. Noller, Susan Froshauer, Harry H. Penner, Jr., William L. Jorgensen, Thomas A. Steitz, and Peter Moore in October 2000 and is headquartered in New Haven, CT. | Direktor/Vorstandsmitglied | - |
Ausbildung von Erik Akhund
| The Trustees of Columbia University in The City of New York | Undergraduate Degree |
| INSEAD | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Melinta Subsidiary Corp.
Melinta Subsidiary Corp. Pharmaceuticals: MajorHealth Technology Melinta Subsidiary Corp. develops and markets pharmaceutical products for the treatment of life-threatening infections. It also develops novel classes of antibiotics to treat the multi- and extremely-drug-resistant pathogens for which there are few to no options, known collectively as ESKAPE pathogens. The company was founded by John N. Abelson, Harry F. Noller, Susan Froshauer, Harry H. Penner, Jr., William L. Jorgensen, Thomas A. Steitz, and Peter Moore in October 2000 and is headquartered in New Haven, CT. | Health Technology |
Quadrant Capital Advisors, Inc.
Quadrant Capital Advisors, Inc. Investment ManagersFinance Quadrant Capital Advisors, Inc. provides investment advisory services. The company was founded on March 04, 2003 and is headquartered in New York, NY. | Finance |
